Skip to main content
Premium Trial:

Request an Annual Quote

Louisville Lands VA Grant for Mass Spec

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The University of Louisville's Proteomics Biomarkers Discovery Core lab has won a $375,000 grant from the US Department of Veterans Affairs to purchase a new mass spectrometer for use in protein assessment, sequencing, glycomic and lipidomic analysis, and tissue imaging.

The Shared Equipment Evaluation Program (ShEEP) grant from the VA, which was won in part through an endorsement from Louisville VA hospital, was bolstered by $125,000 from the university's School of Medicine.

The ShEEP program is run by the VA's Veterans Health Administration Office of Research and Development and aims to provide common resources or shared equipment for biomedical research that benefits veterans.

"The new mass spectrometer purchased with funds from this grant will give us both a high level of sophistication in analysis as well as a high degree of productivity," Jon Klein, director of the lab and principal investigator on the grant, said in a statement. "In short, it gives us both quality and quantity in mass spectrometry, something we need to take our research and diagnostic capabilities to the next level."

The new mass spec instrument will be uses for studies focused on kidney disease, lung disease, alcoholism and liver diseases, kidney stones and acute kidney injury, drug dosing requirements, and others.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.